in the United States since 1999.
(4) It is imperative for people suffering from pain to
get the relief they need while minimizing the potential for
negative consequences.
(5) The human suffering caused by drug addiction,
including the effect on the loved ones of the individuals
suffering from drug addiction, has now reached epidemic
proportions in this Commonwealth.
Section 3. Definitions.
The following words and phrases when used in this act shall
have the meanings given to them in this section unless the
context clearly indicates otherwise:
"Abuse-deterrent opioid analgesic drug product." A brand or
generic opioid analgesic drug product approved by the United
States Food and Drug Administration with abuse-deterrence
labeling claims indicating its abuse-deterrent properties are
expected to deter or reduce its abuse.
"Cost-sharing." The cost to an individual insured under a
health insurance plan according to any coverage limit,
copayment, coinsurance, deductible or other out-of-pocket
expense requirements imposed by the health insurance plan.
"Health insurance carrier." An entity that offers or issues
a health insurance plan and is subject to any of the following:
(1) The act of May 17, 1921 (P.L.682, No.284), known as
The Insurance Company Law of 1921.
(2) The act of December 29, 1972 (P.L.1701, No.364),
known as the Health Maintenance Organization Act.
(3) 40 Pa.C.S. Ch. 61 (relating to hospital plan
corporations) or 63 (relating to professional health services
plan corporations).
20160SB1305PN1905 - 2 -
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30